Blastomycosis is a chronic fungal disease that primarily affects the lower respiratory tract. The acute inflammatory phase of the primary pulmonary infection is characterized by a lymphohematogenous spread to extrapulmonary sites, especially the skin. The presence of disseminated infection with Blastomyces dermatitidis in the larynx is unusual. In areas of the United States where this fungus is endemic, failure to consider laryngeal involvement might lead to inappropriate therapy and thus worsening inflammation and airway compromise.
References
1.
VasquezJ.E., MehtaJ.B., AgrawalR., SarubbiF.A.Blastomycosis in northeast Tennessee. Chest1998; 114: 436–43.
2.
RederP.A., NeelH.B.IIIBlastomycosis in otolaryngology: Review of a large series. Laryngoscope1993; 103: 53–8.
3.
ChapmanS.W., LinA.C., HendricksK.A.Endemic blastomycosis in Mississippi: Epidemiological and clinical studies. Semin Respir Infect1997; 12: 219–28.
4.
HansonJ.M., SpectorG., El-MoftyS.K.Laryngeal blastomycosis: A commonly missed diagnosis. Report of two cases and review of the literature. Ann Otol Rhinol Laryngol2000; 109: 281–6.
5.
DennisF.L.Blastomycosis of the upper respiratory tract, with a report of a case primary in the larynx. Ann Otol Rhinol Laryngol1918; 27: 571–83.
6.
SwinburnC.R., PozniakA.L., DaviesD.G.Left recurrent laryngeal nerve palsy as the presenting feature of sarcoidosis. Sarcoidosis1996; 3: 67–8.
7.
ChijimatsuY., TajimaJ., WashizakiM., HommaH.Hoarseness as an initial manifestation of sarcoidosis. Chest1980; 78: 779–81.
8.
SuenJ.Y., WetmoreS.J., WetzelW.J., CraigR.D.Blastomycosis of the larynx. Ann Otol Rhinol Laryngol1980; 89: 563–6.
9.
DumichP.S., NeelH.B.IIIBlastomycosis of the larynx. Laryngoscope1983; 93: 1266–70.
10.
BradsherR.W.Blastomycosis: Fungal infections of the lung update: 1989. Semin Respir Infect1990; 5: 105–10.
11.
VaalerA.K., BradsherR.W., DaviesS.F.Evidence of subclinical blastomycosis in forestry workers in northern Minnesota and northern Wisconsin. Am J Med1990; 89: 470–6.
12.
WitorschP., UtzJ.P.North American blastomycosis: A study of 40 patients. Medicine (Baltimore)1968; 47: 169–200.
13.
SarosiG.A., KingR.A.Apparent diminution of the blastomycin skin test: Follow-up of an epidemic of blastomycosis. Am Rev Respir Dis1977; 116: 785–8.
14.
JordanM.M., ChawlaJ., OwensM.W., GeorgeR.B.Significance of false-positive serologic tests for histoplasmosis and blastomycosis in an endemic area. Am Rev Respir Dis1990; 141: 1487–90.
15.
BradsherR.W.Systemic fungal infections: Diagnosis and treatment. I. Blastomycosis. Infect Dis Clin North Am1988; 2: 877–98.
16.
DismukesW.E., BradsherR.W.Jr., Cloud GC, et al. Itraconazole therapy for blastomycosis and histoplasmosis. NIAID Mycoses Study Group. Am J Med1992; 93: 489–97.
17.
PappasP.G., BradsherR.W., KauffmanC.A.Treatment of blastomycosis with higher doses of fluconazole. The National Institute of Allergy and Infectious Diseases Mycoses Study Group. Clin Infect Dis1997; 25: 200–5.
18.
BradsherR.W.Histoplasmosis and blastomycosis. Clin Infect Dis1996; 22(Suppl 2): S102–11.
19.
MukkamalaR., MehtaJ.B., MyersJ.W., ColeC.P.Pulmonary blastomycosis with acute respiratory failure as predominant clinical feature. South Med J1997; 90: 847–50.
